Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: Conjugates based on core oligosaccharides

Glycoconjugate Journal

Volumn 31, Issue 1, 2014, Pages 25-39

  St Michael, F ^a   Cairns, C M ^a   Filion, A L ^a   Biolchi, A ^b   Brunelli, B ^b   Giuliani, M ^b   Richards, J C ^a   Cox, A D ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Conjugate vaccine; Core oligosaccharide; LPS; Neisseria meningitidis

Indexed keywords

ANIMALS; BACTERIAL VACCINES; EPITOPES; LIPOPOLYSACCHARIDES; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; OLIGOSACCHARIDES; RABBITS; VACCINES, CONJUGATE;

EID: 84895089980     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-013-9500-z     Document Type: Article

References (15)

1. Jakel, A., Plested, J.S., Hoe, J.C., Makepeace, K., Gidney, M.A.J., et al.: Naturally occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures. Vaccine 26, 6655-6663 (2008)
2. Schmiel, D.H., Moran, E.E., Keiser, P.B., Brandt, B.L., Zollinger, W.D.: Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis. Infect. Immun. 79, 4146-4156 (2011)
3. Weynants, V., Denoel, P., Devos, N., Janssens, D., Feron, C., et al.: Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect. Immun. 77, 2084-2093 (2009)
4. Bonhevi, P., Boutriau, D., Casellas, J., Weynants, V., Feron, C., Poolman, J.: Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults. Clin. Vaccine Immunol. 17, 1460-1466 (2010)
5. Cheng, H., Yang, Z., Estabrook, M.M., John, C.M., Jarvis, G.A., et al.: Human lipooligosaccharide IgG that prevents endemic meningococcal disease recognises an internal lacto-N-neotetraose structure. J. Biol. Chem. 286, 43622-43633 (2011)
6. Plested, J.S., Makepeace, K., Jennings, M.P., Gidney, M.A.J., Lacelle, S., Brisson, J.R., Cox, A.D., et al.: Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect. Immun. 67, 5417-5426 (1999)
7. Gidney, M.A.J., Plested, J.S., Lacelle, S., Coull, P.A., Wright, J.C., Makepeace, K., et al.: Development, characterisation and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide (LPS) epitopes in Neisseria meningitidis. Infect. Immun. 72, 559-569 (2004)
8. Plested, J.S., Harris, S.L., Wright, J.C., Coull, P.A., Makepeace, K., Gidney, M.A.J., et al.: Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia. J. Infect. Dis. 187, 1223-1234 (2003)
9. Cox, A.D., Zou, W., Gidney, M.A.J., Lacelle, S., Plested, J.S., Makepeace, K., et al.: Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23, 5045-5054 (2005)
10. Cox, A.D., St. Michael, F., Neelamegan, D., Lacelle, S., Cairns, C.M., Richards, J.C.: Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading. Glycoconj. J. 27, 401-417 (2010)
11. Cox, A.D., St. Michael, F., Neelamegan, D., Lacelle, S., Cairns, C.M., Giuliani, M.M., Biolchi, A., Hoe, J.C., Moxon, E.R., Richards, J.C.: Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading. Glycoconj. J. 27, 643-648 (2010)
12. Giuliani, M.M., Santini, L., Brunelli, B., Biolchi, A., Arico, B., Di Marcello, F., et al.: The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect. Immun. 73, 1151-1160 (2005)
13. Sawardeker, D.G., Sloneker, J.H., Jeanes, A.: Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal. Chem. 37, 1602-1604 (1965)
14. Cox, A.D., St. Michael, F., Cairns, C.M., Lacelle, S., Filion, A., Neelamegan, D., Wenzel, C.Q., Richards, J.C.: Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera. Glycoconj. J. 28, 165-182 (2011)
15. St. Michael, F., Cairns, C., Neelamegan, D., Filion, A., Lacelle, S., Cox, A.D.: Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica. Glycoconj. J. 28, 397-410 (2011)